Male Reproductive Cancers Resource Center

Viewpoints

High Rates of Overdetection of Recurrence of Prostate Cancer

High Rates of Overdetection of Recurrence of Prostate Cancer

Prostate specific antigen (PSA) screening in some cases led to overdetection of prostate cancer, and now the same is occurring with recurrence.

New ASCO/CCO Prostate Cancer Guidelines Emphasize Quality of Life

New ASCO/CCO Prostate Cancer Guidelines Emphasize Quality of Life

The right time for American Society of Clinical Oncology (ASCO) and Cancer Care Ontario (CCO) on metastatic castration-resistant prostate cancer.

Feature Articles

Controversies and Challenges Surrounding Treatment for Renal Cell Carcinoma

Controversies and Challenges Surrounding Treatment for Renal Cell Carcinoma

Despite concerns that sunitinib may hasten disease progression after therapy, a recent trial refutes that claim, while other patient-related challenges of treating RCC have come to light.

Male Reproductive Cancers Resources

More Male Reproductive Cancers Resources

Managing Bone Health in Prostate Cancer

This fact sheet answers some common questions about prostate cancer, bone scan, and metastasis.

Prostate Cancer: What to Know About Screening, Diagnosis

This fact sheet reviews current prostate cancer screening tests, guidelines, PSA, and risk factors.

Testicular Cancer Fact Sheet

This fact sheet provides information on symptoms, pain, causes, and treatments for testicular, testicle cancer.

ZYDELIG® (idelalisib) for Relapsed Follicular B-cell Non-Hodgkin Lymphoma (FL)

ZYDELIG® (idelalisib) for Relapsed Follicular B-cell Non-Hodgkin Lymphoma (FL)

This slideshow reviews drug information for ZYDELIG® (idelalisib), indicated for relapsed follicular non-Hodgkin lymphoma (FL).

Table of Contents

Slide 3: Indication, Dosage, ...

ZYDELIG® (idelalisib) for Relapsed Chronic Lymphocytic Leukemia

ZYDELIG® (idelalisib) for Relapsed Chronic Lymphocytic Leukemia

This slideshow reviews drug information for ZYDELIG® (idelalisib), indicated for relapsed chronic lymphoma.

Table of Contents

Slide 3: Indication, Dosage, and Administration
Slide ...

ZYKADIA™ (ceritinib)

ZYKADIA™ (ceritinib)

This slideshow reviews drug information for ZYKADIA™ (ceritinib), indicated for anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC).

Table ...

PURIXAN® (mercaptopurine [6-MP] oral suspension)

PURIXAN® (mercaptopurine [6-MP] oral suspension)

This slideshow reviews drug information for PURIXAN® (mercaptopurine [6-MP] oral suspension), indicated for acute lymphoblastic leukemia.

Table of Contents

Slide 3: Indication, ...

SYLATRON® (peginterferon alfa-2b)

SYLATRON® (peginterferon alfa-2b)

Review slide-by-slide drug information for SYLATRON® (peginterferon alfa-2b) for treatment of melanoma.

Table of Contents

Slide 3: Indication, Dosage, and Administration
Slide 8: ...

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs